Charles Schwab’s NGM Biopharmaceuticals, Inc. Common Stock NGM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q2 | – | Sell |
|
|||||
|
2024
Q1 | $453K | Buy |
|
|||||
|
2023
Q4 | $239K | Buy |
|
|||||
|
2023
Q3 | $294K | Buy |
|
|||||
|
2023
Q2 | $704K | Sell |
|
|||||
|
2023
Q1 | $1.33M | Sell |
|
|||||
|
2022
Q4 | $1.65M | Buy |
|
|||||
|
2022
Q3 | $4.12M | Buy |
|
|||||
|
2022
Q2 | $4M | Buy |
|
|||||
|
2022
Q1 | $4.57M | Buy |
|
|||||
|
2021
Q4 | $4.97M | Buy |
|
|||||
|
2021
Q3 | $5.79M | Buy |
|
|||||
|
2021
Q2 | $3.59M | Buy |
|
|||||
|
2021
Q1 | $4.77M | Buy |
|
|||||
|
2020
Q4 | $3.98M | Buy |
|
|||||
|
2020
Q3 | $2.06M | Buy |
|
|||||
|
2020
Q2 | $1.62M | Buy |
|
|||||
|
2020
Q1 | $996K | Buy |
|
|||||
|
2019
Q4 | $1.46M | Buy |
|
|||||
|
2019
Q3 | $561K | Buy |
|
|||||
|
2019
Q2 | $564K | Buy |
|